Gli Anticoagulanti Orali Non Vitamina K-dipendenti Nei Pazienti Con Fibrillazione Atriale Non Valvolare ed End-stage Renal Disease (ESRD). Un Matrimonio Impossibile?

Gli Anticoagulanti Orali Non Vitamina K-dipendenti Nei Pazienti Con Fibrillazione Atriale Non Valvolare ed End-stage Renal Disease (ESRD). Un Matrimonio Impossibile?

Abstract non disponibile (Cardionephrology)

Bibliographic Details
Main Authors:	Di Lullo Luca, Fulvio Floccari, Rodolfo Rivera, Vincenzo Barbera, Antonio Bellasi, Mario Cozzolino, Antonio Selvi, Francesca Santoboni, Antonio De Pascalis, Claudio Ronco
Format:	Article
Language:	Italian
Published:	AboutScience Srl 2017-05-01
Series:	Giornale di Clinica Nefrologia e Dialisi
Subjects:	Anticoagulation therapy Atrial fibrillation Chronic kidney disease Non-vitamin-K oral anticoagulants (NOACs) Warfarin
Online Access:	https://journals.aboutscience.eu/index.php/gcnd/article/view/653

Similar Items

Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program
by: Rabih R. Azar, et al.
Published: (2021-06-01)

Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-Analysis
by: Chun En Yau, et al.
Published: (2023-12-01)

Fibrillazione Atriale e Malattia Renale Cronica
by: Luca Di Lullo, et al.
Published: (2014-12-01)

Association of perioperative thromboprophylaxis on revision rate due to infection and aseptic loosening in primary total hip arthroplasty – new evidence from the Nordic Arthroplasty Registry Association (NARA)
by: Thea Emily Benson, et al.
Published: (2022-04-01)

Fracture Risks in Patients Treated With Different Oral Anticoagulants: A Systematic Review and Meta‐Analysis
by: Huei‐Kai Huang, et al.
Published: (2021-04-01)

Risk of postoperative bleeding following dental extractions in patients on antithrombotic treatment
by: Mohammed AlSheef, et al.
Published: (2021-11-01)

Direct Oral Anticoagulants and Timing of Hip Fracture Surgery
by: Seth M. Tarrant, et al.
Published: (2020-07-01)

Uptake of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation – a prospective cohort study
by: Matylda Zimny, et al.
Published: (2017-02-01)

Non-vitamin K antagonist oral anticoagulants for COVID-19 thrombosis
by: Adel Khalifa Sultan Hamad
Published: (2022-01-01)

Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study
by: Maxim Grymonprez, et al.
Published: (2023-02-01)

Chronic haemothorax: an important cause of pleural effusion
by: David K. Z. Ching, et al.
Published: (2021-06-01)

Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants
by: Raphael Chinedu Anakwue
Published: (2020-01-01)

Trends in anticoagulant prescribing: a review of local policies in English primary care
by: Katherine H. Ho, et al.
Published: (2020-04-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
by: Alexander T. Cohen, et al.
Published: (2018-05-01)

Perception of dental professionals towards dental management of patients using antithrombotic medications in Saudi Arabia: A cross-sectional survey
by: Mohammed AlSheef, et al.
Published: (2020-01-01)

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation
by: Jose Miguel Calderon, et al.
Published: (2022-01-01)

Safety profile of outpatient diagnostic catheterization procedures in patients under direct-acting oral anticoagulants
by: Cristina Ramírez Guijarro, et al.
Published: (2019-08-01)

Rates of Intracranial Hemorrhage in Mild Head Trauma Patients Presenting to Emergency Department and Their Management: A Comparison of Direct Oral Anticoagulant Drugs with Vitamin K Antagonists
by: Gabriele Savioli, et al.
Published: (2020-06-01)

New Direct Oral Anticoagulants (DOAC) and Their Use Today
by: Heike Schwarb, et al.
Published: (2016-03-01)

Novel Oral Anti Coagulants (NOACs) as Anti Thrombotic on Atrial Fibrillation Patients
by: Abed Nego Okthara Sebayang
Published: (2020-02-01)

Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation—One-Year Survival
by: Shmuel Tiosano, et al.
Published: (2023-10-01)

Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational Study
by: Dorotea Bozic, et al.
Published: (2023-08-01)

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study
by: Sola Han, et al.
Published: (2021-08-01)

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants
by: Jo-Nan Liao, et al.
Published: (2022-07-01)

Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort study
by: Maxim Grymonprez, et al.
Published: (2022-09-01)

The preoperative management of dabigatran and its specific antidote idarucizumab in patients with nonvalvular atrial fibrillation: Case reports
by: Tomić Milan
Published: (2020-01-01)

Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults – a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing
by: Christina Sommerauer, et al.
Published: (2017-10-01)

Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis
by: Anthony Chan, et al.
Published: (2018-11-01)

Management of Antithrombotic Agents in Oral Surgery Maria Martinez and Dimitrios A. Tsakiris *
by: Maria Martinez, et al.
Published: (2015-10-01)

Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms
by: Angela Saviano, et al.
Published: (2022-11-01)

Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland
by: Michał Terlecki, et al.
Published: (2023-03-01)

Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
by: Emma Kirstine Laugesen, et al.
Published: (2019-11-01)

Review of Therapeutic Options for the Prevention of VTE in Total Joint Arthroplasty
by: Jordan Etscheidt, et al.
Published: (2020-03-01)

Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
by: Tarun Dalia, et al.
Published: (2021-02-01)

Atrial fibrillation and coronary artery disease: a review on the optimal use of oral anticoagulants
by: Pier Paolo Bocchino, et al.
Published: (2021-09-01)

The Prescription trends and dosing appropriateness analysis of novel oral anticoagulants in ischemic stroke patients: a retrospective study of 9 cities in China
by: Mingfen Wu, et al.
Published: (2024-03-01)

Management of Traumatic Brain Injury in Patients with DOAC Therapy–Are the “New” Oral Anticoagulants Really Safer?
by: Anna Antoni, et al.
Published: (2022-10-01)

A Rare Case of Apixaban-Induced Subdural Hematoma in Elderly Heart Failure Patient
by: Abdirahman Ahmed S, et al.
Published: (2023-09-01)

Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis
by: Stefan Reers, et al.
Published: (2018-10-01)